InVivo Therapeutics Holdings Corp (OTCQB:NVIV)

2.97
Delayed Data
As of Mar 05
 -0.07 / -2.30%
Today’s Change
0.47
Today|||52-Week Range
3.12
+125.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-9.1M-34.7M4.7M-38.8M
 
 
 
 
 
Depreciation44.9K144.7K366.9K740.7K
 
 
 
 
 
Total Other Cash Flow6.3M27.2M-16.1M23.0M
 
 
 
 
 
Funds From Operations-2.7M-7.3M-11.1M-15.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-71.5K84.6K-874.2K-145.8K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.6M-7.4M-10.2M-14.9M
 
 
 
 
 
 
InvestingCapital Expenditures-146.3K-278.9K-2.1M-748.5K
 
 
 
 
 
Net Cash Flow Investing-146.3K-278.9K-2.1M-748.5K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings700.0K134.4K1.7M491.8K
 
 
 
 
 
Long Term Debt Reduction-591.0K-24.8K-336.7K-89.9K
 
 
 
 
 
Net Proceeds Stock Sale11.4M3.0M19.4M16.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing11.5M3.1M20.8M16.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash8.7M-4.6M8.5M1.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account